Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis

Area of Science:

• Cell Biology
• Genetics
• Molecular Medicine

Background:

• Mutations in the human NPHP5 gene are linked to retinal and renal diseases.
• The precise molecular function of NPHP5 and its role in disease pathogenesis remain unclear.
• Understanding NPHP5 function is critical for developing therapeutic strategies.

Purpose of the Study:

• To elucidate the molecular mechanism of NPHP5 in ciliogenesis.
• To investigate the interactions of NPHP5 with other proteins like Cep290 and CaM.
• To explore the impact of disease-causing mutations on NPHP5 function and localization.

Main Methods:

• Depletion studies to observe NPHP5 function in ciliogenesis.
• Analysis of NPHP5 interactions with Cep290 and CaM.
• Investigation of disease-associated and modifier mutations in NPHP5.
• Drug screening to identify compounds that rescue ciliogenesis defects.

Main Results:

• NPHP5 is a centriolar protein essential for an early step of ciliogenesis.
• NPHP5 interacts with Cep290 for ciliogenesis and CaM to prevent self-aggregation.
• Disease-causing mutations prevent Cep290 binding and centrosomal localization, inhibiting cilia formation.
• A modifier mutation affects CaM binding but not ciliogenesis.
• Certain drugs can rescue ciliogenesis defects in NPHP5-depleted cells.

Conclusions:

• NPHP5 plays a vital role in ciliogenesis, and its dysfunction underlies NPHP5-related diseases.
• The findings reveal the molecular basis of NPHP5 deficiency and identify potential therapeutic targets.
• Drug-based interventions show promise for mitigating NPHP5-related ciliopathies.